Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Next PLC Regulatory Filings 2018

Nov 2, 2018

4824_rns_2018-11-02_6e6cba96-5909-4ba4-bda6-bc6a1d5ae227.html

Regulatory Filings

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 2008G

NEX Group PLC

02 November 2018

RNS ANNOUNCEMENT

For Immediate Release                                                                                   2 November 2018

NEX GROUP HOLDINGS LIMITED

RE-REGISTRATION OF NEX GROUP HOLDINGS PLC TO NEX GROUP HOLDINGS LIMITED

In connection with the acquisition of NEX Group plc by CME Group Inc. and CME London Limited implemented by way of a scheme of arrangement under Part 26 of the Companies Act 2006 which was announced on the London Stock Exchange on 2 November 2018, NEX Group Holdings plc hereby announces that it has re-registered from a Public Limited Company to a Private Limited Company and changed its name to NEX Group Holdings Limited.

The current listed and admitted securities of NEX Group Holdings Limited will continue to be listed on the Official List of the United Kingdom Listing Authority and admitted to trading of the Securities on the London Stock Exchange and the NEX Exchange, respectively.

Enquiries:

NEX Group plc
Alex Dee, Head of Investor Relations +44 (0) 207 050 7420
Bryony Bushnell, Head of Media Relations +44 (0) 207 818 9689

Terms used in this notice, but not defined herein, shall have the meaning given to such terms

in the terms and conditions of the respective securities.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

MSCFLLFBVFFXFBK